| scholarly article | Q13442814 |
| P50 | author | Mustapha Si-Tahar | Q40037871 |
| Catherine Werts | Q92157279 | ||
| P2093 | author name string | Fany Blanc | |
| Yann Nouët | |||
| Stefano Cairo | |||
| Ju Chen | |||
| Minou Adib-Conquy | |||
| Yu Wei | |||
| Grégory Jouvion | |||
| Ali Tebbi | |||
| Thierry Tordjmann | |||
| Jennifer Dahan | |||
| Marie-Annick Buendia | |||
| Florence Levillayer | |||
| Anne-Marie Cassard-Doulcier | |||
| Lauriane Remy | |||
| P2860 | cites work | FHL2 (SLIM3) is not essential for cardiac development and function | Q39455832 |
| The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation. | Q39996662 | ||
| Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin | Q40486121 | ||
| Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice | Q41204512 | ||
| Hypothalamic vasopressin release and hepatocyte Ca 2+ signaling during liver regeneration: an interplay stimulating liver growth and bile flow | Q44602920 | ||
| IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
| Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo | Q48000638 | ||
| The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis. | Q53267726 | ||
| Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma | Q58619568 | ||
| A rat fatty liver transplant model | Q70665158 | ||
| Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation | Q71832696 | ||
| Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4 | Q74261317 | ||
| Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis | Q83679148 | ||
| SKI activates Wnt/beta-catenin signaling in human melanoma | Q24298640 | ||
| FHL2, a novel tissue-specific coactivator of the androgen receptor | Q24601620 | ||
| Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts | Q24651323 | ||
| NF-κB, the first quarter-century: remarkable progress and outstanding questions | Q26822516 | ||
| Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain | Q28142613 | ||
| Identification of the LIM protein FHL2 as a coactivator of beta-catenin | Q28216665 | ||
| Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB | Q28508403 | ||
| Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
| NF-kappaB functions as a tumour promoter in inflammation-associated cancer | Q29614598 | ||
| Ubiquitin signalling in the NF-kappaB pathway | Q29616322 | ||
| The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts | Q31113643 | ||
| FHL2, UBC9, and PIAS1 are novel estrogen receptor alpha-interacting proteins | Q33211123 | ||
| TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. | Q33292102 | ||
| Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation | Q33737707 | ||
| The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex | Q33748985 | ||
| Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice | Q33815903 | ||
| FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner | Q34014506 | ||
| The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. | Q34184539 | ||
| Liver regeneration: from myth to mechanism | Q34354926 | ||
| Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration | Q34368036 | ||
| The multifunctional roles of the four-and-a-half-LIM only protein FHL2. | Q34481193 | ||
| NF-κB and STAT3 - key players in liver inflammation and cancer | Q35347976 | ||
| Four-and-a-half LIM domain proteins inhibit transactivation by hypoxia-inducible factor 1 | Q35838885 | ||
| IKK biology | Q35848596 | ||
| The four and a half LIM-only protein 2 (FHL2) activates transforming growth factor β (TGF-β) signaling by regulating ubiquitination of the E3 ligase Arkadia. | Q36543763 | ||
| Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. | Q37073709 | ||
| NF-kappaB signaling, liver disease and hepatoprotective agents | Q37302741 | ||
| Hierarchies of NF-κB target-gene regulation | Q37902866 | ||
| Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription | Q38329033 | ||
| The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b | Q39234696 | ||
| The LIM-only protein FHL2 regulates interleukin-6 expression through p38 MAPK mediated NF-κB pathway in muscle cells | Q39341942 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 3299-3308 | |
| P577 | publication date | 2013-06-17 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis | |
| P478 | volume | 33 |
| Q41182528 | Autophagy Induced FHL2 Upregulation Promotes IL-6 Production by Activating the NF-κB Pathway in Mouse Aortic Endothelial Cells after Exposure to PM2.5. |
| Q51608667 | Deficiency of FHL2 attenuates airway inflammation in mice and genetic variation associates with human bronchial hyper-responsiveness. |
| Q36429362 | Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stress |
| Q33991611 | Differences in the expression of chromosome 1 genes between lung telocytes and other cells: mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells and lymphocytes |
| Q55457293 | Differential Effects of Estrogen Receptor β Isoforms on Glioblastoma Progression. |
| Q37637908 | FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection |
| Q47871595 | FHL2 interacts with EGFR to promote glioblastoma growth |
| Q35137904 | FHL2 regulates hematopoietic stem cell functions under stress conditions |
| Q92814967 | Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury |
| Q34411166 | Identification of gene regulation patterns underlying both oestrogen- and tamoxifen-stimulated cell growth through global gene expression profiling in breast cancer cells. |
| Q40324906 | LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression |
| Q92185461 | LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway |
| Q40614757 | LIM-only protein FHL2 regulates experimental pulmonary Schistosoma mansoni egg granuloma formation |
| Q41684152 | Molecular Analysis of a Short-term Model of β-Glucans-Trained Immunity Highlights the Accessory Contribution of GM-CSF in Priming Mouse Macrophages Response. |
| Q58699735 | PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability |
| Q37225511 | Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation |
| Q33870920 | The Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2 |
| Q27301282 | The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induced fibrosis |
| Q21132015 | Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells |
Search more.